Home » Topics » Regulatory

Regulatory
RSS

Provalis obtains U.K. marketing rights to Pennsaid topical solution

Jan. 12, 2001

FDA approves Femara for first-line treatment of breast cancer

Jan. 11, 2001

Expanded phase III trial program in bipolar disorder announced for Seroquel

Jan. 10, 2001

Argatroban sNDA filed for HIT patients undergoing PCI

Jan. 10, 2001

IND submitted for salmon calcitonin as oral osteoporosis treatment

Jan. 9, 2001

Marketing agreement with Bioglan for Solaraze expanded by SkyePharma

Jan. 8, 2001

U.K. MCA grants marketing clearance for Periostat tablets

Jan. 5, 2001

Major advances in infertility treatment announced by Serono

Jan. 5, 2001

Remicade is first drug approved for inhibiting progression of joint damage in RA

Jan. 3, 2001

New use claimed by Sanofi-Synthelabo for succinic acid derivatives

Dec. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...